| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/03/1998 | CA2040955C Benzimidazole derivatives, their production and use |
| 02/03/1998 | CA2011956C Sodium hyaluronate composition |
| 02/03/1998 | CA1339660C Derivatives of cyclohexane |
| 02/01/1998 | CA2184546A1 Method for treating pediatric high grade astrocytoma including brain stem glioma |
| 02/01/1998 | CA2184545A1 Cancer treatment with temozolomide |
| 01/31/1998 | CA2211866A1 .beta.-adrenergic agonists |
| 01/31/1998 | CA2209690A1 Therapeutic drug for acne vulgaris |
| 01/29/1998 | WO1998003671A1 Process for preparing docosahexaenoic acid and docosapentaenoic acid |
| 01/29/1998 | WO1998003573A1 Angiogenic inhibitory compounds |
| 01/29/1998 | WO1998003554A1 Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same |
| 01/29/1998 | WO1998003551A1 Cd6 ligand |
| 01/29/1998 | WO1998003542A1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 01/29/1998 | WO1998003539A1 G-protein coupled receptor hnfds78 |
| 01/29/1998 | WO1998003530A1 Novel erythromycin derivatives, method for preparing same and use thereof as drugs |
| 01/29/1998 | WO1998003519A2 New bis-platinum complexes with polyamine ligands as antitumor agents |
| 01/29/1998 | WO1998003518A2 New bis-platinum complexes with polymethylene derivatives as ligands having antitumor activity |
| 01/29/1998 | WO1998003516A1 Phosphinate based inhibitors of matrix metalloproteases |
| 01/29/1998 | WO1998003511A1 New triazolopurines, method of preparing them and their use as drugs |
| 01/29/1998 | WO1998003510A1 Azolo triazines and pyrimidines |
| 01/29/1998 | WO1998003507A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 01/29/1998 | WO1998003502A1 Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels |
| 01/29/1998 | WO1998003496A1 Furan nitrone compounds |
| 01/29/1998 | WO1998003494A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 01/29/1998 | WO1998003493A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands |
| 01/29/1998 | WO1998003492A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/29/1998 | WO1998003487A1 Compounds, compositions and methods for treating influenza |
| 01/29/1998 | WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 01/29/1998 | WO1998003476A1 Anilinopeptide derivatives |
| 01/29/1998 | WO1998003473A1 Compounds with growth hormone releasing properties |
| 01/29/1998 | WO1998003472A1 Alpha-amino acid amides, preparation thereof and the therapeutical use thereof |
| 01/29/1998 | WO1998003469A1 Benzoylpropionic acid ester derivatives |
| 01/29/1998 | WO1998003458A1 Illudin analogs useful as antitumor agents |
| 01/29/1998 | WO1998003260A1 Novel adsorbent |
| 01/29/1998 | WO1998003259A1 Novel adsorbent |
| 01/29/1998 | WO1998003207A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| 01/29/1998 | WO1998003204A1 Covalent polar lipid conjugates with biologically-active compounds for use in salves |
| 01/29/1998 | WO1998003202A1 Sorbefacients |
| 01/29/1998 | WO1998003201A1 Novel medicinal compositions for therapeutic use |
| 01/29/1998 | WO1998003196A1 Intradermal bovine polynucleotide vaccine |
| 01/29/1998 | WO1998003185A1 Remedies for hyperphosphatemia |
| 01/29/1998 | WO1998003182A2 Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients |
| 01/29/1998 | WO1998003180A2 Use of sex steroids function modulators to treat wounds and fibrotic disorders |
| 01/29/1998 | WO1998003178A2 Pharmaceutical compositions containing p2y purinergic receptor antagonists |
| 01/29/1998 | WO1998003177A1 Method of treating sinusitis with uridine triphosphates and related compounds |
| 01/29/1998 | WO1998003175A1 Treatment of obesity |
| 01/29/1998 | WO1998003174A1 Method for treating tumors having high ldl requirements employing mtp inhibitors |
| 01/29/1998 | WO1998003173A1 Methods for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
| 01/29/1998 | WO1998003171A2 Use of inhibitors of cyp2a6 for regulating nicotine metabolism |
| 01/29/1998 | WO1998003170A1 Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same |
| 01/29/1998 | WO1998003169A1 Antioxidant activity of 3-dehydroshikimates |
| 01/29/1998 | WO1998003168A1 Composition of micro-organisms containing omega-3-fatty acid useful as a prophylactic or therapeutic agent against parasitary diseases of animals |
| 01/29/1998 | WO1998003167A1 Isobutylgaba and its derivatives for the treatment of pain |
| 01/29/1998 | WO1998003166A1 Thiol sulfonamide metalloprotease inhibitors |
| 01/29/1998 | WO1998003165A1 New use of xylitol and pharmaceutical compositions therefor |
| 01/29/1998 | WO1998003164A1 Thiol sulfone metalloprotease inhibitors |
| 01/29/1998 | WO1998003162A1 Medicinal compositions |
| 01/29/1998 | WO1998003158A2 Ephedrine in granular form with a high active substance content |
| 01/29/1998 | WO1998003157A1 Granulates of hexahydropyrazine derivatives which can be administered orally |
| 01/29/1998 | WO1998003156A2 Topically applied composition for hormone replacement therapy |
| 01/29/1998 | WO1998003137A1 Transdermal drug delivery matrix for coadministering estradiol and another steroid |
| 01/29/1998 | WO1998003069A1 Method for lowering serum lipid levels employing an mtp inhibitor in combination with another cholesterol lowering drug |
| 01/29/1998 | WO1998003067A1 S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
| 01/29/1998 | WO1997048391A3 Methods and compositions comprising r-ibuprofen |
| 01/29/1998 | WO1997047270A3 Novel anti-viral compounds |
| 01/29/1998 | WO1997037630A3 Spiro(2h-1-benzopyran-2,4'-piperidine)-4(3h)-one derivatives, acid addition salts thereof and pharmaceutical compositions containing them |
| 01/29/1998 | WO1997036609A3 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest |
| 01/29/1998 | DE19630390A1 Proteine, insbesondere Membranproteine von Helicobacter pylori, ihre Herstellung und Verwendung Proteins, especially membrane proteins from Helicobacter pylori, their preparation and use |
| 01/29/1998 | DE19630035A1 Tramadol Multiple Unit Formulierungen Tramadol multiple unit formulations |
| 01/29/1998 | DE19629976A1 Verwendung von 4-(p-Halogenphenyl)-3-morpholinopyrrol-2-carbonsäuremethylester zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen Using 4- (p-halophenyl) -3-morpholinopyrrol-2-carboxylic acid methyl ester for the prophylaxis and treatment of the sequelae of acute and chronic cerebral hypoperfusion and neurodegenerative diseases |
| 01/29/1998 | DE19629433A1 Omega-3-fettsäurenenthaltende Zubereitung aus Mikroorganismen als Prophylaktikum bzw. Therapeutikum gegen parasitäre Erkrankungen beim Tier Omega-3 fatty acids containing preparation of microorganisms as a prophylactic or therapeutic agent against parasitic diseases in animals |
| 01/29/1998 | DE19629378A1 Neue Triazolopurine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Triazolopurine new, processes for their preparation and their use as medicaments |
| 01/29/1998 | CA2632790A1 Use of sex steroid function modulators to treat wounds and fibrotic disorders |
| 01/29/1998 | CA2261750A1 Remedies for hyperphosphatemia |
| 01/29/1998 | CA2261674A1 Use of uridine triphosphates and related compounds for the prevention and treatment of pneumonia in immobilized patients |
| 01/29/1998 | CA2261662A1 Sorbefacients |
| 01/29/1998 | CA2261566A1 Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| 01/29/1998 | CA2261162A1 Method for treating tumors having high ldl requirements employing mtp inhibitors |
| 01/29/1998 | CA2261031A1 Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands |
| 01/29/1998 | CA2260995A1 Method for lowering serum lipid levels employing an mtp inhibitor in combination with another cholesterol lowering drug |
| 01/29/1998 | CA2260990A1 Pyrazolopyridine compound and pharmaceutical use thereof |
| 01/29/1998 | CA2260983A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 01/29/1998 | CA2260982A1 Certain substituted benzylamine derivatives; a new class of neuropeptide-y1 specific ligands |
| 01/29/1998 | CA2260860A1 Thiol sulfonamide metalloprotease inhibitors |
| 01/29/1998 | CA2260859A1 Thiol sulfone metalloprotease inhibitors |
| 01/29/1998 | CA2260825A1 Furan nitrone compounds |
| 01/29/1998 | CA2260799A1 Compounds, compositions and methods for treating influenza |
| 01/29/1998 | CA2260253A1 Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety |
| 01/29/1998 | CA2259552A1 Method of treating sinusitis with uridine triphosphates and related compounds |
| 01/29/1998 | CA2259212A1 Ephedrine in granular form with a high active substance content |
| 01/29/1998 | CA2258074A1 Benzoylpropionic acid ester derivatives |
| 01/29/1998 | CA2256736A1 New triazolopurines, method of preparing them and their use as drugs |
| 01/29/1998 | CA2232142A1 Cd6 ligand |
| 01/29/1998 | CA2227423A1 Methods for regulating nicotine metabolism |
| 01/28/1998 | EP0821068A2 Novel sphingolipids and a process thereto |
| 01/28/1998 | EP0820998A2 Novel coumarin quinolone carboxylic acids and processes for the preparation thereof |
| 01/28/1998 | EP0820991A2 Cycloalkyl derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820990A2 Novel benzimidazole, benzoxazole, and benzothiazole derivatives useful as interleukin 1beta inhibitors |
| 01/28/1998 | EP0820988A2 Imino derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820985A1 Bis imide derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/28/1998 | EP0820772A1 Immunomodulating medicinal agent |